Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuanli Chemical Group Co., Ltd., formerly known as Shandong Yuanli Science and Technology Co., Ltd., is a leading Chinese fine chemical company specializing in the research, development, and production of high-end chemical intermediates. The company is a global leader in the production of dicarboxylic acid dimethyl esters (MDBE) and plasticizers, as well as diols like 1,6-hexanediol and 1,5-pentanediol. While primarily an industrial chemical manufacturer, its products serve as essential raw materials and intermediates for various sectors, including pharmaceuticals, coatings, and polymers. Headquartered in Weifang, Shandong, the company is publicly traded on the Shanghai Stock Exchange and maintains a strong focus on green chemistry and sustainable manufacturing processes. The company's pharmaceutical-grade intermediates are utilized by global manufacturers in the synthesis of active pharmaceutical ingredients (APIs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Yuanli Science and Technology.